The allure of the largest U.S. technology companies is understandable given significant returns last year, but their sheer size is the reason for their eventual downfall and long-term stock underperformance, according to Rob Arnott, founder of Research Affiliates.
Linda Radach has had six hip replacement operations since 2006, three on each side. Osteoarthritis was the reason she needed surgery in the first place, but replacing her hips in some ways only worsened her troubles.
Following two of the procedures, the implanted metal socket didn’t integrate with the bone of her own hip socket and was loose, causing excruciating pain. Most recently,....More>>>
Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”
The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.
The fancy clothing company is desperate to find....More>>>
As the stock market inches toward the end of the year, among the four car manufacturers that sell the most cars in the United States, there is one clear loser in the stock market. FordMotor Co. (NYSE: F) shares are down sharply, off 12%.
Wall Street has not been kind to the auto industry in general during 2016. While the S&P 500 is up 10%, General Motors Co.(NYSE: GM) stock is higher....More>>>
Blue-chip companies rightfully make up the bulk of most people’s investment portfolios. These large-cap firms possess considerable industry leverage, as well as a vast sum of financial resources. Their status and importance to the underlying economy means that they are the least likely to crumble, regardless of external pressures. Ultimately, blue chips provide the confidence and stability....More>>>
After the company reported positive results from a mid-stage study evaluating its novel approach to tackling blood cancer, shares in Kite Pharma, Inc. (NASDAQ:KITE) surged 34.6% higher in February, according to S&P Global Market Intelligence.
Kite Pharma’s lead product candidate is axicabtagene ciloleucel, a chimeric antigen receptor T-cell....More>>>
Making it in the finance field is tough. Making it as a woman is even tougher.
The eat what you kill mentality coupled with an often boys club work environment (think Susan Antila’s “Tales From The Boom Boom Room”) has been a less than stellar place for women to succeed. Today, women make up 16% of financial advisors across the country. Compare....More>>>
When buying a home, the most important numbers for mortgage lenders are the buyer’s credit score and the buyer’s debt-to-income ratio. The first is a summary of how the buyer has been managing debt and the second indicates whether the lender can reasonably expect the borrower to be